The global whole slide imaging market size is expected to be worth USD 1933.85 million by 2029 from USD 737.93 million in 2024, growing at a CAGR of 21.25% from 2024 to 2029.
The whole slide Imaging is used mainly for clinical purposes. Whole slide images are primarily used for remotely viewing pathology slides. Digital pathology is increasing day by day due to an increase in advanced technology, such as data transfer speeds, advances in software, and cloud storage solutions. As a result, pathology departments have started using digital imaging for image preservation and image analysis. Recently, pathology laboratories have designed whole slide imaging facilities, which are used in various applications in diagnosis and research.Furthermore, fast image acquisition, efficient data storage, repeatable data analyses across experiments, automated analyses, and easy and instantaneous data sharing drive the whole slide imaging market forward. Advanced digital scanners, visualization methods, and the integration of artificial intelligence-derived algorithms with these systems provide opportunities for the whole slide imaging market to accelerate further. Based on concepts of artificial intelligence and deep learning OS-SiA scanner is built to identify the cell area.On the other hand, the high installation and maintenance costs and some other technical issues are restraining the whole slide imaging market growth. In addition, limited technologies, digital slide storage, and the problem with scanning material and image quality are significant challenges to the whole slide imaging market.
The COVID-19 pandemic has accelerated the growth rate of the whole slide imaging market. The covid-19 pandemic has spread worldwide, resulting in the closure of many industries, including hospitals. Transportation and supply chains have been disrupted due to lockdowns. The COVID-19 pandemic has driven the growth of the whole slide imaging market due to the adoption of digital pathology for remote pathology diagnoses. This technology helps pathologists remotely care for patients from anywhere in the world. Due to the Covid-19 pandemic, telehealth has become more popular; digital whole slide imaging can send the computer-generated scan right to the telehealth team for a clear view of the patient’s problem. It provides a clear image without compressing the image. Due to covid -19 pandemic, many academic teaching methods have changed in institutions to stop the spread of the novel coronavirus. This resulted in increasing digital pathology education tools during the Covid-19 era. Teaching in pathology using digital teaching materials gives students a higher quality image and good interaction. As a result, considering all these factors, the market has had favorable growth during this pandemic period.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Analysed |
By Product, Application, End-user, And Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Market Leaders Profiled |
GE Healthcare, Hologic Inc., Leica Microsystems GmbH. |
Based on the product, the hardware segment accounted for the largest share of the global whole slide imaging market in 2022. This segment is further anticipated to continue showing domination throughout the forecast period owing to the acceptance of a wide range of appearance functionality and an increasing number of product innovations. This helps to speed up the scanning process for imaging.
Based on the application, the cancer segment led the whole slide imaging market with the largest share in 2022 due to the increasing number of cancer cases and advanced treatments. In 2021, nearly 11 million people died due to cancer disease. The most common cancers are breast, lung, colon and rectum, and prostate. This cancer is caused due to increasing consumption of tobacco use, alcohol consumption, and lack of physical activity. Whole slide imaging is used for cancer diagnosis for clear digital images for further decisions.
The pharmaceutical & biopharmaceutical companies’ segment registered the highest share of the global whole slide imaging market in 2022, owing to the increasing investments in drug discovery and the growing launch of new products. Whole slide imaging is used to know the relationship between various biological features.
The Asia Pacific led the market, accounting for a significant share of the global whole slide imaging market in 2022. Because using whole slide imaging advanced technology and e-learning and tele-education in this region drive the market forward. China dominated the APAC whole slide imaging market in 2022. Cloud-based telepathology system has been used in China due to the shortage of pathologists in hospitals. This device uses dual video and data drives to solve the problem of complex data interaction in telemedicine. It is used for quality diagnosis for China people. There are 9840 licensed pathologists in China, according to statistics from the National Ministry of Health. In recent years all types of Whole slide imaging scanners have been available in Japan, each with a unique format.
In 2021, the North American whole slide imaging market had a substantial global market share. Of increasing medical errors and death in the United States every year, they adopted this Whole Slide Imaging system to reduce medical errors and gives accurate patient data driving the market in this region. Approval of the US FDA for a Whole slide imaging system to use in primary surgical pathology diagnosis created a wide range of acceptance and application of this technology in this region. In addition, the Canadian Academy of Pathology has virtual books used in different cases for teaching purposes.
During the forecast period, the European whole slide imaging market is anticipated to showcase a promising CAGR. The Latin American region is predicted to register a moderate CAGR during the forecast period.
Companies playing a dominating role in the global whole slide imaging market profiled in this report are Philips, Siemens, Positron Corporation, Agfa-Gevaert N.V., CardiArc Ltd., Digirad Corporation, Gamma Medica Inc., GE Healthcare, Hologic Inc., Leica Microsystems GmbH, Nikon Corporation, Visiopharm, 3Dhistech, Hamamatsu Photonics KK, and Indica Labs.
In 2021, Royal Philips launched new AI-enabled innovations in MR imaging. It is used to speed up MR exams and to improve diagnostic quality.
Leica Biosystems announced that it had received approval from the U.S. FDA to use Aperio WebViewer for remote diagnosis during the COVID-19 pandemic 2020.
This research report on the global whole slide imaging market has been segmented and sub-segmented based on product, application, end-user, and region.
By Product
By Application
By End-User
By Region
Frequently Asked Questions
The global whole slide imaging market size was valued at USD 608.6 million in 2023.
The North American whole slide imaging market size is anticipated to grow by USD 640.49 million by 2029.
Between 2022 to 2027, the European whole slide imaging market is anticipated to be growing at a CAGR of 20.32%.
Geographically, the APAC region registered the leading share among all the regions in the global whole slide imaging market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region